A Multicenter Extension Study of Taliglucerase Alfa in Adult Subjects With Gaucher Disease
NCT01422187
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
19
Enrollment
INDUSTRY
Sponsor class
Conditions
Gaucher Disease
Interventions
DRUG:
Taliglucerase alfa
Sponsor
Pfizer